Inherited polyposis and early onset colorectal cancer - germline testing

Gene: MBD4

Amber List (moderate evidence)

MBD4 (methyl-CpG binding domain 4, DNA glycosylase)
EnsemblGeneIds (GRCh38): ENSG00000129071
EnsemblGeneIds (GRCh37): ENSG00000129071
OMIM: 603574, Gene2Phenotype
MBD4 is in 5 panels

2 reviews

Arina Puzriakova (Genomics England Curator)

After NHS Genomic Medicine Service consideration, the rating of this gene has not been changed and remains Amber.
Created: 30 Jan 2023, 5:43 p.m. | Last Modified: 30 Jan 2023, 5:43 p.m.
Panel Version: 2.3
Comment on list classification: This gene will be flagged for GMS expert review to determine the suitability of MBD4 for malignancy predisposition testing.

MBD4 was first added by an external reviewer to the 'Haematological malignancies cancer susceptibility' panel (https://panelapp.genomicsengland.co.uk/panels/59/gene/MBD4/), however after GMS consideration it was decided that it should remain amber (v2.23).

Loss of MBD4 leads to an accumulation of somatic CpG>TpG transitions, consistent with MBD4 function which involves repair of G:T mismatches resulting from deamination of 5'-methylcytosine. Germline MBD4 inactivation can therefore lead to somatic variation (i.e. CpG>TpG) in well-known cancer driver genes, in turn conferring cancer susceptibility. Although MBD4 itself does not directly drive oncogenesis, evidence suggests it may modify disease risk as shown by multiple cases reported in literature with this distinctive mutational signature.

Given that there are now two separate Green clinical reviews suggesting this gene, it will again be flagged for further GMS review.
Created: 5 Jul 2022, 3:15 p.m. | Last Modified: 6 Jul 2022, 9:43 a.m.
Panel Version: 1.32
- Palles et al. 2022 (PMID: 35460607) reported on 5 individuals from 4 families with biallelic MBD4 variants who had a personal and/or family history of adenomatous colorectal polyposis (5/5), AML (1/5 personal), and uveal melanoma (2/5 personal). Consistent with previous studies, MBD4-deficient colorectal adenomas showed a significantly increased mutational burden compared to sporadic colorectal tumours, which were mostly attributable to an excess of CpG>TpG transitions.

- Sanders et al. 2018 (PMID: 30049810) demonstrated in 3 individuals with AML (including 2 sibs) and LoF variants in MBD4, that MBD4-deficient cancers exhibit a unique mutational signature with high burden of CpG>TpG transitions. Note that PMID: 32239153 refer to the same individuals.

The MBD4-related hypermutator phenotype has also been detected in Mbd4 mutant mice (PMID:12417741) and other human cancers such as uveal melanoma and colorectal tumours (PMID: 29760383; 32239153; 31322271).
Created: 5 Jul 2022, 3:13 p.m. | Last Modified: 5 Jul 2022, 3:13 p.m.
Panel Version: 1.19

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Multi-organ tumour predisposition syndrome; Adenomatous colorectal polyposis; Colorectal cancer; Acute myeloid leukemia; Uveal melanoma

Publications

Claire Palles (University of Birmingham)

Green List (high evidence)

Bi-allelic loss of function mutation carriers at high risk of early onset AML, colorectal polyposis an uveal melanoma. Heterozygous monoallelic carriers at no significantly increased risk in data so far.
Sources: Literature
Created: 30 Jun 2022, 10:47 a.m.

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
polyposis; CRC; AML; MDS; UVM

Publications

Details

Mode of Inheritance
BIALLELIC, autosomal or pseudoautosomal
Sources
  • NHS GMS
  • Expert Review Amber
  • Literature
Phenotypes
  • Multi-organ tumour predisposition syndrome
  • Adenomatous colorectal polyposis
  • Colorectal cancer
  • Acute myeloid leukemia
  • Uveal melanoma
OMIM
603574
Clinvar variants
Variants in MBD4
Penetrance
Complete
Publications
Panels with this gene

History Filter Activity

30 Jan 2023, Gel status: 2

Removed Tag, Removed Tag, Removed Tag

Arina Puzriakova (Genomics England Curator)

Tag Q3_22_rating was removed from gene: MBD4. Tag Q3_22_NHS_review was removed from gene: MBD4. Tag Q3_22_expert_review was removed from gene: MBD4.

30 Jan 2023, Gel status: 2

Added New Source

Arina Puzriakova (Genomics England Curator)

Source NHS GMS was added to MBD4.

5 Jul 2022, Gel status: 2

Entity classified by Genomics England curator

Arina Puzriakova (Genomics England Curator)

Gene: mbd4 has been classified as Amber List (Moderate Evidence).

5 Jul 2022, Gel status: 2

Added Tag, Added Tag, Added Tag

Arina Puzriakova (Genomics England Curator)

Tag Q3_22_rating tag was added to gene: MBD4. Tag Q3_22_NHS_review tag was added to gene: MBD4. Tag Q3_22_expert_review tag was added to gene: MBD4.

5 Jul 2022, Gel status: 2

Created, Added New Source, Set mode of inheritance, Set publications, Set Phenotypes, Set penetrance

Arina Puzriakova (Genomics England Curator)

gene: MBD4 was added gene: MBD4 was added to Inherited polyposis. Sources: Literature,Expert Review Amber Mode of inheritance for gene: MBD4 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: MBD4 were set to 12417741; 30049810; 32239153; 35460607 Phenotypes for gene: MBD4 were set to Multi-organ tumour predisposition syndrome; Adenomatous colorectal polyposis; Colorectal cancer; Acute myeloid leukemia; Uveal melanoma Penetrance for gene: MBD4 were set to Complete